Tick-Borne Pathogen â€“ Reversed and Conventional Discovery of Disease by Ellen Tijsse-Klasen et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PUBLIC HEALTH
REVIEW ARTICLE
published: 07 July 2014
doi: 10.3389/fpubh.2014.00073
Tick-borne pathogen – reversed and conventional
discovery of disease
EllenTijsse-Klasen1*, Marion P. G. Koopmans1,2 and Hein Sprong1
1 Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands
2 Erasmus Medical Center, Rotterdam, Netherlands
Edited by:
Juan-Carlos Navarro, Universidad
Central de Venezuela, Venezuela
Reviewed by:
Peter Kraiczy, University Hospital of
Frankfurt, Germany
Peter James Krause, Yale School of
Public Health, USA
*Correspondence:
Ellen Tijsse-Klasen, RIVM, Postbus 1,
3720 BA Bilthoven, Netherlands
e-mail: ellen.tijsseklasen@gmail.com
Molecular methods have increased the number of known microorganisms associated with
ticks significantly. Some of these newly identified microorganisms are readily linked to
human disease while others are yet unknown to cause human disease. The face of tick-
borne disease discovery has changed with more diseases now being discovered in a
“reversed way,” detecting disease cases only years after the tick-borne microorganism was
first discovered. Compared to the conventional discovery of infectious diseases, reverse
order discovery presents researchers with new challenges. Estimating public health risks
of such agents is especially challenging, as case definitions and diagnostic procedures
may initially be missing. We discuss the advantages and shortcomings of molecular meth-
ods, serology, and epidemiological studies that might be used to study some fundamental
questions regarding newly identified tick-borne diseases.With increased tick-exposure and
improved detection methods, more tick-borne microorganisms will be added to the list of
pathogens causing disease in humans in the future.
Keywords: tick-borne pathogens, public health, Rickettsia, Neoehrlichia mikurensis, Ixodes ricinus, Borrelia
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INTRODUCTION
Molecular methods, especially polymerase chain reaction (PCR),
have brought huge changes to tick-borne disease research in the
last two decades. A vast number of new microorganisms have
been detected in ticks (1, 2), leading to an increase in reversed-
disease discovery, where the microorganism is identified before
its causal relationship with a disease is established (3–5). Several
years can pass between the first detection of a microorganism in
ticks and the first identification of a human case (4, 6). It is often
unclear whether these novel tick-borne diseases were previously
overlooked or if they were absent. Though molecular methods are
not yet broadly used diagnostically, their increasing use in outpa-
tient settings, as well as hospital settings, will improve the chance
to identify novel tick-related microorganisms as causative agents
of disease in future. There is a call for research on the growing lists
of both new tick-related microorganisms with unknown patho-
genicity and novel tick-borne pathogens for which the ecology,
epidemiology, and full clinical picture are unknown, to elucidate
their impact on public health.
DISCOVERY OF TICK-BORNE DISEASES
REVERSED DISCOVERY OF TICK-BORNE DISEASES
Modern molecular methods enable the exploration of bacterial
and viral communities in ticks without needing culturing. Since
the 1990s, many studies have identified microorganisms in ticks
that are distinct from known pathogens but cluster genetically
with them. Frequently encountered bacteria in ticks with (initially)
unknown pathogenicity are relatives of Anaplasma, Bartonella,
Ehrlichia, and Wolbachia, and an increasing number of Rickettsia
species (1, 2, 7). Now, we try to identify diseases caused by known
microorganisms instead of looking for microorganisms causing
known diseases (8, 9). This has led to an increase in pathogens
about which only a few case reports exist and the disease burden –
including clinical picture, severity, and incidence – is unclear.
Examples of reversed-disease discovery include Neoehrlichia
mikurensis, Borrelia miyamotoi, and some Rickettsia species. N.
mikurensis was discovered in 1999 in ticks by PCR and has since
been reported in several countries (7, 10–12). Since 2010, serious
diseases in immuno-compromised patients and mild disease in
otherwise healthy individuals were associated with this bacterium
(4, 13–16). Similarly, B. miyamotoi was found to cause disease in
patients with febrile illness, Lyme, or anaplasmosis-like diseases
years after it had been detected in ticks (5, 17–22). Rickettsia hel-
vetica and Rickettsia monacensis had also first been identified in
ticks before disease cases were linked to them (3, 23). These exam-
ples show that tick-borne infections can go unnoticed for various
reasons. They might resemble known diseases or be overlooked
due to non-specific symptoms. Furthermore, a lower disease inci-
dence, due to a low exposure rate or due to a small susceptible
population, can contribute to delayed discovery.
Ongoing developments in the field of next generation sequenc-
ing will deliver more sequence data of microorganisms in ticks
(24). From this pool of microorganisms with unknown patho-
genicity, more tick-borne pathogens could arise.
CONVENTIONAL DISCOVERY OF TICK-BORNE DISEASES
In contrast to reversed-disease discovery, conventional disease
discovery starts with the identification of cases and the correla-
tion with tick bites is recognized afterwards. This is facilitated if
one or several of the following properties characterize the illness:
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serious disease course, temporal, or geographic clustering of cases
or illness with characteristic symptoms (often a rash). These
properties facilitate case definitions and epidemiological source
tracing, thereby linking disease, tick-bite, and pathogen to a full
etiological picture. Subsequently, the list of symptoms linked to
the specific syndromes might be expanded, as demonstrated by
the example of Lyme borreliosis.
In modern history, first correlations between tick bites and dis-
ease were observed around the turn of the last century (25). The
first recognized tick-borne disease in humans was Rocky Moun-
tain spotted fever (RMSF) (25), which drew attention since 1870s
due to its high fatality rate, geographic and temporal clustering,
and economic impact (26). Howard T. Ricketts identified the tick
vector and the pathogen responsible for the disease (25, 26). Sim-
ilarly to RMSF, tick-borne encephalitis (TBE) was identified in
Russia due to the temporal clustering of cases that initiated an
intensive search for the pathogen. The virus was isolated in 1937
(27). There have been severe cases with fatality rates between 1
and 40% depending on the subtype (28). Currently, the most
commonly recognized tick-borne disease in humans is Lyme bor-
reliosis, caused by members of the B. burgdorferi s.l. complex.
Lyme borreliosis lacks the high mortality of RMSF and TBE but
its typical rash, erythema migrans (EM) was recognized by Arvid
Afzelius and other dermatologists in Europe in the early twenti-
eth century (29, 30). There is a long list of differential diagnostics
for other symptoms associated with Lyme borreliosis, including
neurological, skeletomuscular, cardiac, and skin conditions (31).
Therefore, the complete clinical spectrum of Lyme borreliosis was
not recognized until 1970s, when an unusually high incidence of
arthritis was observed in a small geographic area of the US (32).
Tick-borne phleboviruses are the most recent pathogens identified
following the conventional discovery route (33, 34). The first tick-
borne phlebovirus was discovered in China after a small cluster of
cases with thrombocytopenia and leukocytopenia provoked active
surveillance for additional cases, identifying 285 patients. Cases
were clustered in rural areas and a tick-borne etiology was soon
suspected. The agent was then identified through metagenomic
analysis of patient samples and later also detected in ticks (33).
More examples for conventional discovery of tick-borne diseases
are given in Table 1.
FROM NON-PATHOGENIC TO ESTABLISHED PATHOGEN
Microorganisms detected in ticks can have different implications
for human health. Some have not been shown to cause dis-
ease in humans while others are established human pathogens.
Non-pathogenic microorganisms detected by molecular meth-
ods in ticks include tick endosymbionts, commensal bacteria, and
residual DNA from earlier blood meals (24, 41, 42). Established
pathogens include agents such as R. rickettsii, TBE, and B. burgdor-
feri s.l., which are well described and known to cause disease.
When tick-borne diseases are identified following the reversed
course of disease discovery, they progress from the category of non-
pathogens to pathogenic microorganisms. However, as informa-
tion about ecology, epidemiology, and clinical picture are initially
lacking, further research is necessary to confirm pathogenicity,
incidence, and geographic distribution. Currently, a number of
novel tick-borne microorganisms fall in this category, including R.
helvetica, N. mikurensis, and B. miyamotoi (34). The public health
relevance of such suspected tick-borne pathogens is unknown and
should be one of the key objectives of further studies. Some of these
novel tick-borne pathogens might be involved in yet unexplained
disease following tick bites or acute or chronic inflammation with-
out known cause. To assess actual health impact and relevance,
a causal relationship needs to be confirmed by a strong line of
evidence, for example, following Koch’s postulates (Box 1). Case
definitions have to be established and prevalence of disease needs
to be estimated.
METHODS FOR THE DISCOVERY OF NOVEL TICK-BORNE
PATHOGENS AND THE ESTIMATION OF THEIR PUBLIC
HEALTH IMPACT
Estimating the disease burden of novel tick-borne diseases and
microorganisms with unknown pathogenicity should be the focus
of research in this area. This requires studies on many levels.
Table 1 | Selection of tick-borne diseases in humans and characteristics associated with their discovery.
Disease (Suspected) Pathogen Disease
first
reported
Characteristic
symptomsa
Temporal/
geographic
clusters
First
isolated
from
Diagnostic
testsb
Rocky Mountain spotted fever Rickettsia rickettsii 1896 Yes Yes Humans Yes (25)
Relapsing fever Borrelia hermsii, B. duttonii 1904 Yes No Humans Yes (35)
Mediterranean spotted fever R. conorii 1910 Yes No Humans Yes (36)
Lyme (erythema migrans) B. burgdorferi sensu lato 1912 Yes No Humans Yes (29)
Tick-borne encephalitis TBE virus 1937 Yes Yes Humans Yes (37)
Human babesiosis Babesia microti, B. divergens 1969 No No Livestock Yes (38, 39)
Lyme (whole syndrome) B. burgdorferi sensu lato 1977 No (Yes) Humans Yes (32)
Anaplasmosis Anaplasma phagocytophilum 1994 No No Livestock Yes (40)
Rickettsiosis R. helvetica 1999 No No Ticks No (3)
Neoehrlichiosis Neoehrlichia mikurensis 2010 No No Ticks No (4)
Lyme-like illness B. miyamotoi 2011 No No Ticks No (5)
aCharacteristic symptoms do not need to occur in all patients with the infection.
bCommercially available diagnostic tests for the specific age.
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Box 1 Tick-borne diseases and Koch’s postulates.
Providing evidence for a causal relationship between a tick-borne microorganism and a certain disease can be challenging. About 120 years
ago, Jakob Henle and his student Robert Koch formulated three postulates to help prove a causal relationship between an infectious agent
and a disease. If the following points are met, it can be concluded that the parasite has a causal relationship with the disease in question
[freely translated from Ref. (43)]:
1. The parasite is found in every case of the disease in question, in circumstances under which it can account for pathological changes and
the clinical course of the disease.
2. The parasite is not found in any other disease as a fortuitous and non-pathogenic parasite.
3. After complete isolation from the body and grown repeatedly in pure cultures, the parasite is again able to produce the disease.
To meet the postulates, the agent must be culturable and cause the same disease invariably in a new host (human or experimental animal).
However, many pathogens, including some novel tick-borne microorganisms, cannot fulfill these premises or lack suitable animal models
(44). Koch was the first to identify asymptomatic carriers of a pathogen and was thus aware of these limitations (43, 45) that also restrict the
applicability of his original postulates for tick-borne pathogens. However, several alternatives have been formulated (46–49). The postulates
of Fredericks and Relman (48) rely on sequence-based detection of pathogen DNA in tissue samples. Making no absolute statements,
they emphasize the importance of higher amounts of DNA and higher incidence of DNA detection in cases compared to controls, while
the DNA load should fall or rise with disease resolution or recurrence. Evans formulated several premises that should be met, including
epidemiological measures (e.g., higher disease incidence in those carrying an organism), host response (e.g., serology), and effectiveness
of preventative measures (46). Other authors acknowledge the value of direct visualization of infectious agent, strain differences, serology,
epidemiology and, especially, combinations of these (46, 47). A conclusive line of evidence for the causal role of an infectious agent in a
specific disease supported by classical or alternative postulates would be ideal, but might not be realistic for some of the novel tick-borne
pathogens in the near future.
Information about the ecology of novel tick-borne diseases,
including the vector, natural cycle, and reservoirs of the microor-
ganism can help to identify high-risk regions and populations.
In the long run, this information could also be helpful in iden-
tifying counteractions such as culling reservoir animals (if com-
patible with nature conservation efforts) or other ways to reduce
tick density. Data about the epidemiology will help to identify
peak periods, estimate disease incidence, and the overall pub-
lic health impact of novel tick-borne pathogens (50). Finally yet
importantly, knowledge about symptoms associated with novel
tick-borne pathogens and knowledge about risk factors provide
health practitioners with tools to identify potential cases. Identify-
ing cases is important to request appropriate diagnostic tests and
initiate appropriate treatment and request appropriate diagnostic
tests. This in turn might help epidemiological data collection.
IDENTIFICATION OF POTENTIAL PATHOGENS IN TICKS AND POSSIBLE
PITFALLS
Microorganisms in ticks are most commonly detected and iden-
tified by PCR and direct sequencing. 16S rDNA library and next
generation sequencing methods have also been used (24, 51–53).
With decreasing costs in the future, the latter will probably gain
importance and open new doors to microbial discovery. Sequenc-
ing several genes of a novel tick-related microorganism can also
give a preliminary estimation of the microorganism’s pathogenic
potential. Some genes, such as the surface protein OspC of B.
burgdorferi sl., might be directly linked to pathogenicity (54).
However,with novel microorganisms, such associations are usually
unknown. A comparison of the microorganisms’ overall genetic
background with that of known pathogens might help. Rick-
ettsia species, for example, are plentiful in invertebrates of which
only a fraction is found in vector species (55). A first evaluation
based on several gene sequences can help to determine whether
a novel Rickettsial species clusters in one of two known groups
that contain human pathogens: the typhus and the spotted fever
group. A Rickettsia species not belonging to one of these pathogen-
containing groups has therefore a lower chance to be pathogenic.
More advanced predictions based on whole genome sequencing
are also underway and might assist in the identification of tick-
borne pathogens in the future (56). However, it should be noted
that molecular techniques have weaknesses, including the inability
to distinguish living and dead cells and the risk of contamination
or PCR artifacts from various sources. Although not yet shown
for ticks, in some cases the detection of a single gene might also
be due to horizontal gene transfer (57). One source of mislead-
ing PCR results was recently discovered. Eggs of a parasitic wasp,
Ixodiphagus hookeri, can be embedded in ticks collected in the field.
The eggs contain Wolbachia but more bacteria or viruses might be
present in them and lead to misleading PCR results (58, 59).
KNOWLEDGE ABOUT ECOLOGICAL FACTORS CAN GUIDE SEARCH FOR
DISEASE
Studying novel tick-borne pathogens and the diseases they cause
can be facilitated by knowledge of the microorganism’s ecology.
Tick species that can act as vectors include generalist species that
readily bite humans (e.g., I. ricinus and Amblyomma americanum)
but also opportunistic species that prefer other vertebrate hosts
(e.g., Rhipicephalus sanguineus) (60). Environmental factors can
influence tick densities and the prevalence of tick-borne microor-
ganisms and can thus influence exposure risks for humans (61–67)
(Figure 1). Understanding the relationships between ecological
factors and the prevalence of tick-borne pathogens as well as
mapping densities of infected ticks can help to identify high-risk
areas for human exposure. Furthermore, knowledge about natural
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FIGURE 1 | A tick-related microorganism must take various steps to cause disease. Each step is influenced by many factors, including the characteristics of
the microorganism. These characteristics affect every step of transmission and are therefore not listed separately.
cycles of vectors, hosts and pathogens might help to predict sea-
sonal variations in pathogen prevalence (50). Even for pathogens
transmitted by the same tick species, peak periods of disease cases
can vary because disease incidence does not only depend on the
questing activity of ticks. First of all, different tick-borne dis-
eases can be transmitted by different tick stages (e.g., Rickettsia
vs. B. burgdorferi) and these differ in their main questing period.
Secondly, the infection rate of ticks with various pathogens can
underlay different seasonal variations as was shown by Coipan
et al. (50). However, if no data are available about seasonality
of novel tick-borne pathogens, peaks in established tick-borne
diseases vectored by the same tick species could indicate simi-
lar seasonal patterns of novel pathogens (50). Aligning the start
and location of epidemiological studies and sampling periods of
serological studies with such high-risk areas and high-risk periods
could improve the chance to identify cases of a novel tick-borne
disease.
SEROLOGY FOR IDENTIFICATION OF EXPOSURE AND CASES
Serological methods have a wide diagnostic window, as antibod-
ies to a pathogen may persist for months or even years. This
makes these assays valuable to investigate past exposure to tick-
borne pathogens. Advantages of serology include the ease of
obtaining samples and ability to detect current infections by sero-
conversion. Serology can be used to investigate infection with
tick-borne pathogens in high-risk populations or those showing
signs of disease with unknown cause. Examples of the latter are
the investigation into possible rickettsial origins of chronic illness
in Australian patients and of liver dysfunctions in Spanish patients
(68, 69). In these studies, patient groups had a higher seropreva-
lence for rickettsial antigens than controls. Cochez and coworkers
screened paired sera of 322 patients with suspicion of tick-borne
infections for the presence of Anaplasma phagocytophilum antigen
and found evidence of infection in about a third of the patients
(70). Such investigations do not prove causal relationships of dis-
ease with a specific tick-borne pathogen but could be the key to
identifying certain clinical entities.
Highly specific serology would facilitate this kind of study.
However, for many tick-borne diseases, serological assays need
improvement as they lack sensitivity or the specificity to differen-
tiate between species or genotypes. For some of the newest tick-
borne diseases, no serological assays are available at all. Fast devel-
opment of serological assays often relies on culture for antigen
production. In cases where cultures are not available, production
of recombinant proteins or synthetic peptides offer an alternative
(22, 71). Both require genetic information on potentially antigenic
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proteins. A further bottleneck in the development of serological
assays is the availability of suitable samples for validation. Espe-
cially if a microorganism is suspected to be involved in disease but
positively identified cases are scarce or lacking, the availability of
well-defined sera for validation purposes is limited. Disregarding
the type of antigen used, the inability to distinguish asymptomatic
infections from disease and lack of immune response under some
circumstances limit the use of serology, as it can only be a mea-
sure for infection risk rather than disease risk (72, 73). For these
reasons, the use of serology in novel tick-borne disease research
is limited but can have increased value when combined with
other methodologies such as molecular detection of pathogens or
large epidemiological studies linking sero-conversion with clinical
manifestations of disease.
MOLECULAR METHODS FOR IDENTIFICATION OF INFECTIONS
The development of serology for novel pathogens generally takes
time, while PCR is often already available or can be set up quickly.
Molecular methods enable testing for tick-borne pathogens for
which no serological assays exist. The limitation of PCR on
patient material, besides contamination risks, lies in the avail-
ability of suitable material. Tissue tropisms differ for different
pathogens or clinical presentations (74). Therefore, the choice of
the tissue to be tested is crucial for success, requiring a certain
degree of knowledge about the pathogenesis of a microorgan-
ism. This can be derived from previous case reports, wildlife and
animal studies, or tissue tropisms of related pathogens. Samples
that might be available for testing include skin biopsies, tissues
removed during medically required surgery, cerebrospinal, syn-
ovial fluids, and blood samples. Blood samples, being so readily
available, will often be the first though potentially not always
the best choice to test for tick-borne pathogens and have been
successfully used (5, 75). Skin biopsies have been useful in the diag-
nosis of rickettsiosis, or for research purposes on various rashes,
including EM (76, 77). Novel tick-borne diseases have not yet
been identified by PCR on skin samples but this may change in
future.
Detection of a microorganisms’ DNA in a single patient does
not prove a causal relationship. The microorganism might not be
the causative agent of the observed disease but a mere asymp-
tomatic co-infection. However, using molecular techniques on
larger case numbers and analyzing the data according to speci-
fied parameters [e.g., with adapted Koch’s postulates (48)] could
help support causal relationships and formulate case definitions.
EPIDEMIOLOGICAL STUDIES TO DEFINE DISEASE INCIDENCE AND
IDENTIFY CASES
Epidemiological studies to link tick bites with health outcome vary
in their design from retrospective to prospective and from case–
control to cohort studies. Prospective cohort studies have been
performed to find associations between tick-borne pathogens and
adverse health effects or serological response (78–82). Prospec-
tive cohort studies combine high precision-of-risk estimations,
the ability to study several outcomes at once, and opportunity to
include (molecular) data collected from ticks, if available. While
past studies with 250–400 tick-bitten participants detected some
Lyme borreliosis cases, they failed to identify cases caused by other
pathogens that might have a lower incidence (either in due to lower
prevalence in ticks or lower infectivity) (81, 82). This highlights
the drawbacks: success of cohort studies depends on the size of
the study population, the fraction of exposed individuals, and the
frequency of the expected outcome in exposed individuals. Conse-
quently, cohort studies are less suitable for uncommon pathogens
or those with a low pathogenicity, unless the cohort is very large.
Studies focusing on syndromic surveillance and diagnosis of high-
risk patients, ideally coupled with case–control studies to identify
causal factors, would be more suitable to detect rare tick-borne
diseases. Identifying a patient group with symptoms or laboratory
findings matching earlier case descriptions increases the chance
of detecting novel tick-borne pathogens in patients (21). Focus-
ing on patients with tick-exposure history or on areas with a high
prevalence of the pathogen will further increase the chance of iden-
tifying cases. Identifying individual cases is crucial to answering
some questions concerning novel tick-borne diseases, such as the
full clinical picture and risk factors. In contrast to individual case
studies, epidemiological studies can supply valuable data to help
risk estimation and disease burden of newly identified tick-borne
diseases.
SUMMARY
Tick-borne disease research has changed greatly since the age of
molecular detection methods. An increasing number of novel
tick-related microorganisms are being identified and this evo-
lution will continue in future due to the increasing availability
of new sequencing methods. Isolated cases of human diseases
caused by novel tick-borne microorganisms can suggest that a
microorganism is pathogenic but they do not provide sufficient
proof of a causal relationship. A causal relationship of a novel
pathogen with a disease would be supported by the use of Koch’s
postulates (Box 1).
The rigid criteria used in the original postulates might not be
suitable, though, in which case modern adaptations of the pos-
tulates can demonstrate a causal role (48, 49). Such alternative
postulates can rely on serology, molecular diagnostics, or epidemi-
ology. Novel tick-borne pathogens could play a role in diseases
with currently unknown etiology, such as chronic fatigue, skele-
tomuscular, and neurological symptoms (5, 20). They might also
explain treatment-resistant symptoms in patients diagnosed with
other tick-borne diseases (20). Knowledge about a pathogen’s ecol-
ogy could be used to guide such studies by identifying high-risk
areas and populations. Ecological knowledge might also be useful
to educate the public and take measures to reduce the density of
infected ticks. Efforts to increase awareness among medical health
professionals, providing diagnostic tools (case definition, serol-
ogy, PCR, etc.) and recommending effective treatment options
will further help to diagnose and treat cases.
The incidence of some tick-borne diseases showed an increase
or fluctuations throughout recent decades due to various fac-
tors, mainly associated with increased tick-exposure (82–84). This
upward trend might extend to newly identified tick-borne diseases
as well, as these also depend on tick-exposure. People with co-
morbidities are more likely to develop (severe) disease following
infection with tick-borne pathogens and this sensitive group is
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growing due to current medical and sociological developments
(4, 21). It is likely that even in the healthy population many cases
caused by novel tick-borne pathogens go unnoticed. The real num-
ber of cases could therefore be significantly higher than currently
apparent. The actual incidence needs to be determined to help
estimate public health impact.
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